ORYZON to Present at the Neuroscience R&D Technologies Conference

- It will be held in Barcelona on December 3 - 4.

BARCELONA, SPAIN and CAMBRIDGE MA.

Oryzon Genomics, a clinical stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative diseases, announced today that Dr. Tamara Maes, Oryzon’s Chief Scientific Officer, will present at the Neuroscience R&D Technologies Conference on December 3 - 4, to be held at hotel Pullman Barcelona Skipper in Barcelona, Spain.

Click here to see the full Press Release